Startups
Dassault Systemes
Vélizy-Villacoublay, France
Dassault Systèmes SE is the French-law European public software corporation behind the 3DEXPERIENCE platform, headquartered in Vélizy-Villacoublay and listed on Euronext Paris as DSY.PA. Its engineering, scientific modeling and simulation technologies support manufacturing, infrastructure and cities, and life sciences and healthcare. Current corporate leadership describes AI-powered 3D UNIV+RSES, data intelligence and virtual twins as core research and business priorities. Its healthcare relevance includes clinical-trial technology through Medidata, molecular and scientific software through BIOVIA, and prescription digital therapeutics through its actual investment in Click Therapeutics. Click’s March19,2025 issuer announcement states that Dassault Systèmes provided the entire Series C, with Medidata as its subsidiary strategic partner. This is a single parent corporate-buyer relationship rather than two independent checks. Cash allocation and individual subscription amounts are not established by the public converted-debt-inclusive regulatory total. The company’s public current management directory names twelve executives; its separate official board roster is preserved as governance rather than a VC partnership. Pascal Daloz became chairman and CEO on February21,2026 after Bernard Charlès stepped down from the chair and board. This legal software corporation is distinct from Dassault Aviation and controlling shareholder Groupe Industriel Marcel Dassault. Its brands, acquired subsidiaries, accelerator projects, commercial partners, public financing and corporate investments are not LP venture-capital funds, and no fund size or portfolio allocation is inferred from corporate revenue, market value or acquisition consideration.
Founded 1981
Team
Anne-Laure ChevalierDirector Representing Employees · Senior Director, Head of Legal Development and Organization (since2018) |
Catherine DassaultDirector |
Catherine JuillardInvestor Relations Contact (public directory) |
Charles EdelstenneFounder, Honorary Chairman and Director |
Christine DefertDirector Representing Employees · Executive Assistant, Industries Organization (since2007) |
Delphine Da Maia-LevyInvestor Relations Contact (public directory) |
Donatella SciutoIndependent Director |
 Elisa PrisnerExecutive Vice President, Strategy, Industry, Marketing & Transformation |
Eric TrappierDirector |
 Erik SwedbergExecutive Vice President, Americas |
 Florence Hu-AubignyExecutive Vice President, Research & Development |
 Florence VerzelenExecutive Vice President, Europe, Middle East, Africa (EMEA) |
Genevieve BergerIndependent Director and Lead Director of Sustainable Development |
 Grégory AbateGeneral Secretary |
Isabelle FuzellierInvestor Relations Contact (public directory) |
Julien MouretInvestor Relations Contact (public directory) |
 Laurence BarthèsExecutive Vice President, Chief People & Information Officer |
Laurence DauresIndependent Director and Lead Independent Director |
Marie DumasInvestor Relations Director |
Marie-Helene Habert-DassaultDirector |
Michele de SouzaInvestor Relations Contact (public directory) |
Nathalie Rouvet LazareIndependent Director |
Olivier Costa de BeauregardBoard Representative of Corporate Director Groupe Industriel Marcel Dassault |
 Pascal DalozChief Executive Officer & Chairman |
 Patrick JohnsonExecutive Vice President, Corporate Research & Sciences |
 Philippe LauferExecutive Vice President, 3DS Global Brands |
 Rouven BergmannExecutive Vice President, Chief Financial Officer |
 Samson KhaouExecutive Vice President, Asia-Pacific |
Soumitra DuttaIndependent Director; Scientific Committee Chair |
 Victoire de MargerieVice President Corporate Marketing, Communication & Identity |
Xavier CauchoisIndependent Director; Audit Committee Chair |
Investments
| $—2025-03-19 |  Click Therapeutics | Dassault Systemes |
| €3.65B2019-09-10 | Dassault Systemes | 0 participations |